Novo Will Work With Anthropic AI to Speed Drug Development

Covered by 2 sources
Read full post
Novo Nordisk has partnered with Anthropic to accelerate drug development through AI, aiming to strengthen its position in the competitive obesity treatment market.

Covered by 2 sources


More in Healthcare

Novo Partners With Anthropic to Speed Up Drug Discovery Using Claude

Covered by 2 sources
Healthcare2 min read

ByteDance’s AI drug unit Anew Labs raises $290M at $1.5B valuation, Reuters reports

The Next Web
Healthcare5 min read

University of Manchester Uses NVIDIA Earth-2 to Forecast Air Pollution Across the UK

Nvidia Blog